Investing.com - Precigen (NASDAQ: PGEN) reported second quarter EPS of $-0.090, worse than the analyst estimate of $-0.083. Revenue for the quarter came in at $856K versus the consensus estimate of $666.67K.
Precigen’s stock price closed at $1.85. It is up 27.590% in the last 3 months and up 69.720% in the last 12 months.
Precigen saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Precigen’s stock price’s past reactions to earnings here.
According to InvestingPro, Precigen’s Financial Health score is "weak performance".
Check out Precigen’s recent earnings performance, and Precigen’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Precigen earnings missed, revenue topped estimates
Published 2 months ago
Aug 15, 2025 at 4:20 AM
Negative
Auto